ChromaDex develops nutraceuticals for aging, Their flagship product Tru Niagen. ChromaDex has used their formulations in many clinical trials supporting the use of nicotinamide riboside (NR). ChromaDex boasts that approximately 70% of clinical trials using NR have used ChromaDex’s formulations. Rober Fried is the current CEO of ChromaDex.